跳至主要内容
临床试验/NCT00281476
NCT00281476已完成1 期

The Effect of High Dose Simvastatine on Multiple Myeloma

Vejle Hospital0 个研究点目标入组 10 人开始时间: 2006年2月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
主要终点
Response estimated by internationally approved criteria after 8 weeks of intermittend treatment with simvastatine

研究概览

简要总结

The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • multiple myeloma-patients in need of treatment
  • stable og progressive disease
  • age = or > 18 years
  • performance status < 3
  • life expectancy > 3 months

排除标准

  • pregnancy
  • patients incapable of giving personally concent
  • renal insufficiens with creatinine clearance below 25 ml/min
  • alanin aminotransferasis > 2,5 x upper reference limit
  • thyroxine below lower reference limit
  • known familiar muscle-disease ar previous myopati
  • creatinine kinase > 10 x upper reference limit
  • medication with drugs with known interactions wiht simvastatine

结局指标

主要结局

Response estimated by internationally approved criteria after 8 weeks of intermittend treatment with simvastatine

时间窗: 8 weeks after treatment start

次要结局

  • Changes in markers of bone metabolisme after 8 weeks of intermittend treatment with simvastatine(8 weeks after start of treatment)
  • Toxicity according to CTC after 8 weeks of intermittend treatment with simvastatine(8 weeks after start of treatment)

研究者

申办方类型
Other

相似试验

The Effect of High Dose Simvastatine on Multiple... | 临床试验